Should I invest in UTI Focussed Equity Fund - Series IV (1104 Days)?

We don't give personal investment advice. UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option is suitable for an investor whose:time horizon is **5+ years** — equity funds can drop 30-50% in bad years; horizons under 5 years materially raise the risk of selling at a lossrisk tolerance accepts seeing the portfolio fall sharply without panic-sellinggoal isn't capital preservation in the short termCross-check the numbers above against alternatives before deciding.

UTI

UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option

Latest NAV

₹10.6409

As of

6 Oct 2020

742 NAV records on file

NAV history & peer comparison

All NAVs split-adjusted and normalised to 100 at the start of the selected period, so funds with very different absolute NAV scales can be compared on one axis.

Period

Add another fund to compare

No matches.

Compares up to 8 funds. Click any line in the legend above to hide/show it.

Returns matrix

Fund return alongside the category average and peer rank for every standard window. Returns under one year are absolute; one year and longer are compound annualised (CAGR).

Window	Fund	Category avg	+/− vs avg	Rank	Quartile
1D	+0.01%	+0.10%	-0.09	55 / 104	Q3
1W	+0.14%	-0.02%	+0.17	40 / 103	Q2
2W	+0.33%	+0.10%	+0.24	40 / 102	Q2
1M	+0.65%	+1.52%	-0.86	74 / 101	Q3
3M	+8.58%	+5.34%	+3.24	22 / 100	Q1
6M	+29.99%	+9.00%	+20.99	6 / 99	Q1
YTD	-2.04%	+4.61%	-6.65	79 / 99	Q4
1Y	+12.72%	+18.02%	-5.30	34 / 90	Q2
2Y	+9.88%	+9.96%	-0.08	39 / 84	Q2
3Y	+1.96%	+13.26%	-11.31	74 / 76	Q4
4Y	—	—	—	—	—
5Y	—	—	—	—	—
7Y	—	—	—	—	—
10Y	—	—	—	—	—
Inception	+2.05%	+11.59%	-9.54	95 / 104	Q4

Quartile legend: Q1 top 25% Q2 25-50% Q3 50-75% Q4 bottom 25%

Calendar-year returns

Full-year performance vs category average. Current year is partial (year-to-date).

Year	Fund	Category avg	+/− vs avg	Rank
2020 YTD	-2.04%	+15.92%	-17.96	58 / 58
2019	+13.45%	+7.18%	+6.27	8 / 69
2018	-10.84%	-5.07%	-5.77	31 / 34
2017	—	—	—	—

Rolling returns

Removes start-date bias by averaging CAGR over every overlapping N-year window in the fund's history. Higher average plus tight min/max plus high "% positive" = consistent.

1-Year rolling

+0.76%

25 windows

min -14.6% · max 21.7%

52% positive

Limited basis — fund is young, so this average may be skewed by which 1Y windows happen to be available.

3-Year rolling

+1.96%

1 window

min 2.0% · max 2.0%

100% positive

Limited basis — fund is young, so this average may be skewed by which 3Y windows happen to be available.

5-Year rolling

—

Insufficient history

7-Year rolling

—

Insufficient history

SIP returns — historical "what if"

If you had invested every month in this fund over the chosen period, this is what your investment would be worth today.

Period

Total invested

₹ —

Today's value

₹ —

XIRR

Annualised

Wealth multiplier

Period	Total invested	Today's value	XIRR	Wealth multiplier

XIRR is the annualised internal rate of return on the SIP cash flow — invariant to the monthly amount. "Today's value" and "Total invested" scale linearly with the slider. Past performance does not guarantee future returns. Excludes exit load and taxes.

Risk profile

Risk-adjusted return and volatility, computed from monthly NAV returns over the trailing 3-year and 5-year windows.

Std deviation

20.34%

3-year · annualised

Sharpe ratio

-0.12

vs risk-free 6.5%

Sortino ratio

-0.15

Downside-only deviation

Max drawdown

-36.58%

Feb 2020 → Mar 2020

% positive months

58.3%

Share of monthly returns > 0 over the 3-year window

Sharpe / Sortino use a risk-free rate of 6.5% (1-year T-bill proxy). Higher Sharpe = more return per unit of total risk; higher Sortino = more return per unit of downside risk.

Peers in Flexi Cap Fund

Scheme	Fund house	NAV	As of
HDFC Flexi Cap Fund - Growth Option - Direct Plan	HDFC	₹2,248.7410	17 Jul 2026
Nippon India Flexi Cap Fund - Direct Plan - Growth Plan - Growth Option	Nippon India	₹17.9459	17 Jul 2026
SBI Flexicap Fund - DIRECT PLAN - Growth Option	SBI	₹121.4251	17 Jul 2026
ICICI Prudential Flexicap Fund - Direct Plan - Growth	ICICI Prudential	₹21.1200	17 Jul 2026
Invesco India Flexi Cap Fund - Direct Plan - Growth	Invesco	₹20.6200	17 Jul 2026
BANDHAN Flexi Cap Fund-Direct Plan-Growth	Bandhan	₹232.8250	17 Jul 2026
quant Flexi Cap Fund - Growth Option-Direct Plan	Quant	₹122.1976	17 Jul 2026
Aditya Birla Sun Life Flexi Cap Fund - Growth - Direct Plan	Aditya Birla Sun Life	₹2,165.0600	17 Jul 2026
Motilal Oswal Flexi cap Fund Direct Plan-Growth Option	Motilal Oswal	₹67.6885	17 Jul 2026
Franklin India Flexi Cap Fund - Direct - Growth	Franklin India	₹1,808.6718	17 Jul 2026

Recent NAVs

Date	NAV
6 Oct 2020	₹10.6409
5 Oct 2020	₹10.6400
1 Oct 2020	₹10.6365
30 Sep 2020	₹10.6163
29 Sep 2020	₹10.6257
28 Sep 2020	₹10.6543
25 Sep 2020	₹10.5333
24 Sep 2020	₹10.3856
23 Sep 2020	₹10.5636
22 Sep 2020	₹10.6054

Frequently asked questions

These answers are generated from this fund's live metrics — NAV, returns, peer rank, drawdown, SIP backtest. Numbers refresh nightly after AMFI's NAV feed lands.

As of 06 Oct 2020, the NAV of UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option is ₹10.6409. It's a Flexi Cap Fund from UTI, run as a Direct plan Growth option. NAVs update once per business day from the AMFI feed.

UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option has NAV history starting from 29 Sep 2017, a track record of about 8 years 9 months. That's enough history to evaluate the fund across one or two market cycles. Look at rolling returns rather than point-to-point to judge consistency.

UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option is managed by UTI. It's classified by AMFI under the 'Flexi Cap Fund' SEBI category, which determines its peer set and tax treatment.

Over the trailing 1-year window, UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option has delivered a absolute return of 12.72% — -5.3 pp behind the Flexi Cap Fund category average of 18.02%. The fund ranks #34 of 90 in its category — the second (Q2) quartile.

Over the trailing 3-year window, UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option has delivered a CAGR of 1.96% — -11.31 pp behind the Flexi Cap Fund category average of 13.26%. The fund ranks #74 of 76 in its category — the bottom (Q4) quartile.

UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option doesn't have a complete 5-year window yet (we need at least 5 year of NAVs). Check the shorter-window returns above.

₹1 lakh invested in UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option exactly 3 years ago would be worth approximately ₹105,991 today — a multiplier of 1.06×, based on the 3-year CAGR of 1.96%. The category average over the same window would have grown ₹1 lakh to ₹145,305.

A ₹10,000 monthly SIP in UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option over the last 3 years — total invested ₹360,000 — would be worth ₹391,029 today. That's an XIRR (money-weighted annualised return) of 5.43%.

UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option doesn't yet have 10 years of NAVs. Over the longest available window (3-year SIP), ₹10,000/month would have grown to ₹391,029 — XIRR 5.43%.

On a 3-year basis, UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option ranks #74 out of 76 funds in the Flexi Cap Fund category — that places it in the bottom quartile (Q4) — material underperformance. The category average return over the same window is 13.26%; this fund delivered 1.96%.

The worst peak-to-trough decline UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option has experienced over the last 3-year window is 36.58% — its NAV fell from a high on 20 Feb 2020 to a low on 23 Mar 2020. Drawdown is a useful gauge of how much short-term pain you'd have endured to capture the long-term return.

Across all 3-year rolling windows, UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option averaged 1.96% (best 1.96%, worst 1.96%). 100% of rolling windows ended positive. The 3-year Sharpe ratio is -0.12 — negative risk-adjusted performance.

In calendar year 2019, UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option returned 13.45% — beating the Flexi Cap Fund category average of 7.18% by 6.27 pp. It ranked #8 of 69 in its category that year.

UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option is classified as an Equity fund (at least 65% equity exposure). Tax rules (post Budget 2024): if you hold 12 months or more, gains are Long-Term and taxed at 12.5% on the amount exceeding ₹1.25 lakh per financial year. Held for under 12 months, gains are Short-Term and taxed at 20%. The ₹1.25 L exemption is per PAN per FY across all equity LTCG.

We don't give personal investment advice. UTI Focussed Equity Fund - Series IV (1104 Days) - Direct Plan - Growth Option is suitable for an investor whose:

time horizon is **5+ years** — equity funds can drop 30-50% in bad years; horizons under 5 years materially raise the risk of selling at a loss
risk tolerance accepts seeing the portfolio fall sharply without panic-selling
goal isn't capital preservation in the short term

Cross-check the numbers above against alternatives before deciding.

Educational content only — not investment advice. Tax rules summarised above reflect Budget 2024; consult a qualified adviser before transacting.